Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific

Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer

Listen now

Description

Shelley Force Aldred and Nathan Trinklein, co-founders of Rondo Therapeutics, on the opportunity with bispecific antibodies for cancer.

More Episodes

See all »

Ep168: Jonathan Bricker on How to Quit Smoking & Prevent Cancer

Jonathan Bricker, professor in the cancer prevention program at Fred Hutchinson Cancer Center, on how to quit smoking with help from tech and biotech tools.

Published 11/25/24

The Long Run with Luke Timmerman

Published 11/25/24

Ep167: Leslie Williams on transfer RNA therapies

Leslie Williams, CEO of Boston-based hC Bioscience, on developing transfer RNA therapies.

Published 11/06/24